| Name | Title | Contact Details |
|---|
Plume is a SaaS company that specializes in cloud-controlled experience management platforms for communication service providers (CSPs) and their subscribers. It operates in over 60 million locations worldwide, focusing on adaptive WiFi, cybersecurity, and network intelligence. The company offers several key services, including HomePass, which provides adaptive WiFi optimization and parental controls for residential users, and WorkPass, which enhances business WiFi networks with real-time monitoring and security features. Plume also supports mobile operators with its 5G.11 Offload service, which helps reduce cellular data costs by switching devices to WiFi networks. Their technology is built on OpenSync, an open-source framework that allows for rapid deployment of services.
Symmetry Labs was founded by artist and technologist Alexander Green in 2014. We are technology company, design studio, and creative agency.
Benevon is a Seattle, WA-based company in the Business Services sector.
Applied BioCode focuses on research and development, manufacturing, and commercialization of assay testing kits and instruments for in vitro diagnostics, research, and other industrial applications. The HQ of the company is at Los Angles, California. The company develops, manufactures, and commercializes multiplex diagnostic testing products. Applied BioCode, Inc. has combined "digital barcodes" with immunochemistry and molecular probes to create a new, bio-inspired Barcoded Magnetic Beads (BMB) technology. The microscale BMB, with a diameter of human hair, is tagged with immunochemistry or molecular probes, allowing the digital barcode to be easily scanned and accurately identified for a very high number (4,096 barcodes) of biological targets with no ambiguity. Applied BioCode, Inc. products focus on the $4.5 billion molecular diagnostic infectious disease segment of the market with assays that detect pathogens for gastrointestinal infections, respiratory infections and other high value diseases. The company has currently received FDA Clearance for the BioCode® MDx-3000 system with a 17-plex Gastrointestinal Pathogen Panel (GPP) and a 17-plex Respiratory Pathogen Panel (RPP). The Gastrointestinal Pathogen Panel (GPP) has also obtained the CE-Mark for use in European countries conforming to CE-Mark regulations. In the face of the COVID-19 pandemic, Applied BioCode, Inc. also manufactures a BioCode® SARS-CoV-2 Assay, authorized by the FDA under the Emergency Use Authorization (EUA). Applied BioCode, Inc. also partners with a variety of diagnostic and pharmaceutical companies with applications that include the infectious disease, autoimmune disease, allergy, gut microbiome, and veterinary diagnostics.